UPDATE: Arrowhead Pharmaceuticals (ARWR) Files $200M Mixed Securities Shelf

October 31, 2016 9:50 AM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
(Updated - October 31, 2016 9:51 AM EDT)

Arrowhead Pharmaceuticals (Nasdaq: ARWR) filed a registration with the U.S. SEC to sell up to $200 million of mixed securities.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Equity Offerings

Add Your Comment